STOCK TITAN

Ingredion announces strategic partnership with Sanstar Limited expanding access to pharma and food ingredient markets in India

(Moderate)
(Very Positive)
Tags
partnership

Ingredion (NYSE: INGR) announced a strategic joint venture with Sanstar Limited, including a 9% equity investment in India’s leading corn-based specialty products manufacturer. The partnership targets high-growth pharma and food ingredient markets in India.

The companies will build a greenfield facility to produce specialty pharmaceutical and other high-value ingredient products, creating a vertically integrated, science-led platform serving food, beverage, pharmaceutical, home and beauty customers and supporting export opportunities from India.

Loading...
Loading translation...

Positive

  • Joint venture with Sanstar to expand in Indian pharma and food ingredients
  • 9% equity stake in India’s leading corn-based specialty products manufacturer
  • Creation of a vertically integrated specialty ingredients platform in India
  • Planned greenfield facility for diversified specialty pharma and ingredient products
  • Access to high-growth specialty starch and functional ingredients market in India
  • Combination of Sanstar’s sourcing/manufacturing with Ingredion’s formulation and go-to-market expertise

Negative

  • None.

News Market Reaction – INGR

-0.72%
-0.72% Session close to close

In the May 28 session, INGR declined 0.72%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement details a strategic joint venture and 9% equity investment in Sanstar to expand ph...
Analysis

This announcement details a strategic joint venture and 9% equity investment in Sanstar to expand pharma and food ingredient exposure in India, including a green field manufacturing project. It builds on Ingredion’s history of partnerships to access high-growth categories. Investors may watch execution of the new Indian platform, demand trends in specialty starches and functional ingredients, and any future use of the existing S-3ASR shelf for related financing or alliances.

Key Figures

Equity stake in Sanstar: 9%
1 metrics
Equity stake in Sanstar 9% Equity investment percentage associated with the joint venture partner in India

Previous Partnership Reports

3 past events · Latest: Jun 18 (Positive)
Same Type Pattern 3 events
Date Event Sentiment 24h Move Catalyst
Jun 18 Distribution expansion deal Positive -0.5% Expanded Univar distribution of Ingredion ingredients into Benelux food producers.
Feb 13 Sweet protein partnership Positive +0.2% Partnership with Oobli to combine sweet proteins with natural sweeteners.
Nov 14 Plant protein JV Positive -5.6% Strategic partnership with Lantmännen to develop pea protein isolates in Europe.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Partnership announcements have often seen muted to negative next-day reactions, with two of three prior deals followed by share price declines.

Recent Company History

Recent partnership news for Ingredion has focused on expanding distribution and broadening specialty ingredient offerings. A November 14, 2024 plant-based protein partnership with Lantmännen and a June 18, 2025 expansion with Univar in Benelux both aimed to strengthen regional positions but saw negative next-day moves. A February 13, 2025 sweet protein collaboration with Oobli had a small positive reaction. Today’s India-focused joint venture fits this pattern of using partnerships to access high-growth niches.

Key Terms

joint venture, equity investment, green field construction project
3 terms
joint venture financial
"announced a joint venture with Sanstar Limited and an equity stake in Sanstar"
A joint venture is when two or more companies team up to work on a specific project or business idea, sharing both the risks and the rewards. It’s like friends starting a lemonade stand together—each contributes resources and they split the profits, making it easier to succeed than going alone.
equity investment financial
"Through the agreement, Ingredion will form a joint venture with Sanstar and make a 9% equity investment"
An equity investment is buying ownership in a company by purchasing its shares, which gives you a claim on future profits and a portion of the company's value. It matters to investors because returns depend on the company’s growth and performance—like owning a slice of a pie that can grow or shrink—so you can gain through rising share prices or dividends but also risk losing value if the business falters.
green field construction project technical
"The companies will commission a green field construction project to manufacture a diversified portfolio"
A green field construction project is building new facilities from scratch on previously undeveloped land, like starting a factory or office campus on an empty lot rather than renovating an existing site. For investors this matters because these projects demand big up-front spending, longer timelines and permit risks but can offer more design freedom, capacity for growth and potentially higher long‑term returns if completed on budget and on time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

WESTCHESTER, Ill., May 28, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions for food, beverage, pharma and industrial markets, announced a joint venture with Sanstar Limited and an equity stake in Sanstar, India’s leading manufacturer of corn-based specialty products. The partnership combines local expertise with global formulation and innovation capabilities to serve high growth pharma and food ingredient verticals in India.

“India represents an increasingly important growth market for Ingredion. Our partnership with Sanstar expands our presence with a reputable local partner that complements our existing businesses in India with the opportunity to scale a broad specialty ingredients platform,” said Jim Zallie, chairman, president and CEO of Ingredion. “Sanstar's sourcing and manufacturing capabilities, combined with Ingredion's formulation and go-to-market expertise, create the opportunity to offer food and pharma customers differentiated offerings to serve the rapidly evolving needs of Indian consumers while also providing export opportunities from India.”

India's specialty starch and functional ingredients market is among the fastest-growing in the Asia-Pacific region, driven by expanding domestic consumption, rising pharmaceutical exports and increasing regulatory focus on clean-label and sustainable formulations.

This venture will quickly establish a local platform for vertically integrated, science-led specialty ingredients and solutions for customers across food, beverage, pharmaceutical, home and beauty categories.

Through the agreement, Ingredion will form a joint venture with Sanstar and make a 9% equity investment in the company. The companies will commission a green field construction project to manufacture a diversified portfolio of specialty pharmaceutical and other ingredient products for high-value end-use markets.

About Ingredion
Ingredion Incorporated (NYSE: INGR), headquartered in the suburbs of Chicago, is a leading global ingredient solutions provider serving customers in more than 120 countries. With 2025 annual net sales of approximately $7.2 billion, the Company turns grains, fruits, vegetables and other plant-based materials into value-added ingredient solutions for the food, beverage, animal nutrition, brewing, pharmaceutical and industrial markets. With Ingredion’s Idea Labs® innovation centers around the world and more than 11,000 employees, the Company co-creates with customers and fulfills its purpose of bringing the potential of people, nature and technology together to make life better. Visit ingredion.com for more information and the latest Company news.

About Sanstar Limited

Sanstar Limited is one of India's leading corn-based specialty products and ingredient solutions companies, engaged in the manufacture of starch, glucose, modified starches, dextrose and other corn derivatives. Listed on BSE (544289) and NSE (SANSTAR), the Company operates state-of-the-art manufacturing facilities and serves a diverse range of industries including food & beverage, pharmaceuticals, animal nutrition, paper, and textiles. Sanstar is committed to sustainable, responsible manufacturing and consistently investing in technology-led growth.

Media Contact:
Rick Wion
rick.wion@ingredion.com


FAQ

What is Ingredion’s (NYSE: INGR) joint venture with Sanstar Limited announced in May 2026?

Ingredion announced a joint venture with Sanstar Limited, including a 9% equity stake in India’s leading corn-based specialty products manufacturer. According to Ingredion, the partnership targets high-growth pharma and food ingredient markets by combining local manufacturing with global formulation and innovation capabilities.

How much equity is Ingredion investing in Sanstar Limited as part of the 2026 partnership?

Ingredion plans to make a 9% equity investment in Sanstar Limited alongside forming a joint venture. According to Ingredion, this minority stake supports a long-term collaboration with India’s leading corn-based specialty producer and helps establish a scalable specialty ingredients platform in the region.

How does the Sanstar joint venture expand Ingredion’s presence in India’s pharma and food ingredient markets?

The joint venture gives Ingredion greater access to India’s high-growth pharma and food ingredient verticals. According to Ingredion, Sanstar’s sourcing and manufacturing will pair with its formulation and go-to-market expertise to offer differentiated specialty starch and functional ingredient solutions for local and export markets.

What new manufacturing capacity will Ingredion and Sanstar build under their 2026 agreement?

Ingredion and Sanstar will commission a greenfield construction project to manufacture diversified specialty pharmaceutical and other ingredient products. According to Ingredion, this facility aims to serve high-value end-use markets across food, beverage, pharmaceutical, home and beauty categories within India and for export.

Why is the Indian specialty starch market important to Ingredion’s strategy with Sanstar?

India’s specialty starch and functional ingredients market is described as among the fastest-growing in Asia-Pacific. According to Ingredion, rising domestic consumption, pharmaceutical exports and clean-label, sustainable formulation trends make India a key growth platform for the new joint venture with Sanstar.

What benefits does the Sanstar partnership offer Ingredion’s food and pharma customers in India?

The partnership is expected to provide differentiated specialty ingredient offerings for food and pharma customers in India. According to Ingredion, combining Sanstar’s manufacturing with its formulation and go-to-market strengths will deliver science-led, vertically integrated solutions tailored to rapidly evolving Indian consumer and regulatory demands.